Case number 1:17-cv-01154
Cephalon, Inc. et al v. Slayback Pharma Limited Liability Company et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 19, 2022 | 419 | USCA Mandate (3) Docket Text: MANDATE of USCA as to [410] Notice of Appeal (Federal Circuit) filed by Fresenius Kabi USA, LLC. USCA Decision: Appeal No. 2020-2136 is dismissed. The revised official caption for appeal nos. 2020-2134 and 2020-2137 is reflected in the order. (fms) |
| Apr 29, 2022 | 441 | Notice (Other) (2) Docket Text: NOTICE of Change of Address of Williams & Connolly, LLP by Cephalon, Inc., Teva Pharmaceuticals International GmbH (Hoeschen, Nathan) |
| Apr 29, 2022 | 442 | Statement (2) Docket Text: STATEMENT Regarding Third-Party Litigation Funding by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Apr 29, 2022 | 443 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Cephalon, Inc., Teva Pharmaceuticals International GmbH filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 1, 2022 | 440 | SO ORDERED (2) Docket Text: SO ORDERED, re [438] Joint MOTION for Leave to File Excess Pages (Unopposed), filed by Mylan Laboratories Limited. Signed by Judge Colm F. Connolly on 2/1/2022. (kmd) |
| Jan 31, 2022 | 438 | Motion for Leave to File Excess Pages (2) Docket Text: Joint MOTION for Leave to File Excess Pages (Unopposed) - filed by Mylan Laboratories Limited. (Lennon, James) |
| Jan 31, 2022 | 439 | Main Document (26) Docket Text: Joint OBJECTIONS by Mylan Laboratories Limited to [428] Bill of Costs, [427] Bill of Costs . (Attachments: # (1) Exhibit 1.1, # (2) Exhibit 1.2, # (3) Exhibit 1.3, # (4) Exhibit 2.1, # (5) Exhibit 2.2, # (6) Exhibit 3.1, # (7) Exhibit 3.2, # (8) Exhibit 3.3, # (9) Exhibit 3.4, # (10) Exhibit 3.5, # (11) Exhibit 4, # (12) Exhibit 5)(Lennon, James) |
| Jan 31, 2022 | 439 | Exhibit 1.1 (3) |
| Jan 31, 2022 | 439 | Exhibit 1.2 (2) |
| Jan 31, 2022 | 439 | Exhibit 1.3 (2) |
| Jan 31, 2022 | 439 | Exhibit 2.1 (2) |
| Jan 31, 2022 | 439 | Exhibit 2.2 (4) |
| Jan 31, 2022 | 439 | Exhibit 3.1 (2) |
| Jan 31, 2022 | 439 | Exhibit 3.2 (12) |
| Jan 31, 2022 | 439 | Exhibit 3.3 (5) |
| Jan 31, 2022 | 439 | Exhibit 3.4 (6) |
| Jan 31, 2022 | 439 | Exhibit 3.5 (4) |
| Jan 31, 2022 | 439 | Exhibit 4 (4) |
| Jan 31, 2022 | 439 | Exhibit 5 (2) |
| Jan 24, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [437] STIPULATION TO EXTEND TIME to submit their Response or Objections to the Bill of Costs to January 31, 2022, filed by Mylan Laboratories Limited. Ordered by Judge Colm F. Connolly on 1/24/2022. (kmd) |
| Jan 21, 2022 | 437 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit their Response or Objections to the Bill of Costs to January 31, 2022 - filed by Mylan Laboratories Limited. (Lennon, James) |
| Jan 12, 2022 | 436 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants Mylan Laboratories Ltd., Apotex Inc. and Apotex Corp. to submit their Response or Objections to the Bill of Costs to January 24, 2022 - filed by Mylan Laboratories Limited. (Lennon, James) |
| Dec 13, 2021 | 434 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME for Defendants Mylan Laboratories Ltd., Apotex Inc., and Apotex Corp. to submit their Response or Objections to the Bill of Costs to January 17, 2022 - filed by Mylan Laboratories Limited. (Lennon, James) |
| Dec 13, 2021 | 435 | Objections (6) Docket Text: OBJECTIONS by Slayback Pharma Limited Liability Company to [429] Bill of Costs Slayback Pharma LLC's Opposition to Plaintiff's Bill of Costs. (Ormerod, Eve) |
| Dec 10, 2021 | 432 | Redacted Document (26) Docket Text: REDACTED VERSION of [430] MEMORANDUM in Support, by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 10, 2021 | 433 | Redacted Document (30) Docket Text: REDACTED VERSION of [431] Declaration by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 3, 2021 | 427 | Bill of Costs (2) Docket Text: BILL OF COSTS by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 3, 2021 | 428 | Bill of Costs (2) Docket Text: BILL OF COSTS by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 3, 2021 | 429 | Bill of Costs (2) Docket Text: BILL OF COSTS by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Nov 19, 2021 | 426 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file a bill of costs to December 3, 2021 - filed by Cephalon, Inc.. (Hoeschen, Nathan) |
| Nov 5, 2021 | 425 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME for Plaintiffs to file a bill of costs to November 19, 2021 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Oct 22, 2021 | 424 | Main Document (2) Docket Text: MANDATE of USCA as to [409] Notice of Appeal (Federal Circuit) filed by Apotex Inc., Apotex Corp., [411] Notice of Appeal (Federal Circuit) filed by Mylan Laboratories Limited. USCA Decision: AFFIRMED. (Attachments: # (1) Judgment)(nmf) |
| Oct 22, 2021 | 424 | Judgment (2) |
| Oct 15, 2021 | 423 | USCA Order (2) Docket Text: ORDER of USCA Decision of USCA: IT IS ORDERED THAT: The petition for panel rehearing is denied. The petition for rehearing en banc is denied. The mandate of the court will issue on October 22, 2021. (nmf) |
| Aug 10, 2021 | 422 | Redacted Document (23) Docket Text: REDACTED VERSION of [420] Joint MOTION to Amend/Correct (Joint Motion to Amend the Judgment Pursuant to a Settlement Agreement) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Aug 5, 2021 | 421 | Judgment (8) Docket Text: FINAL JUDGMENT ORDER. Signed by Judge Colm F. Connolly on 8/5/2021. (fms) |
| Aug 18, 2020 | 416 | Appeal Transcript Request (1) Docket Text: TRANSCRIPT REQUEST by Mylan Laboratories Limited TRANSCRIPT NOT NEEDED (Lennon, James) |
| Aug 18, 2020 | 417 | Appeal Transcript Request (1) Docket Text: TRANSCRIPT REQUEST by Fresenius Kabi USA, LLC TRANSCRIPT NOT NEEDED (Farnan, Michael) |
| Aug 18, 2020 | 418 | Transcript Request (1) Docket Text: TRANSCRIPT REQUEST TRANSCRIPT NOT NEEDED by Apotex Corp., Apotex Inc.. (Tancredi, Damien) |
| Aug 6, 2020 | 413 | USCA Notice of Docketing ROA (3) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [409] Notice of Appeal (Federal Circuit) filed by Apotex Inc., Apotex Corp.. USCA Case Number 2020-2134 (fms) |
| Aug 6, 2020 | 414 | USCA Notice of Docketing ROA (3) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [411] Notice of Appeal (Federal Circuit) filed by Mylan Laboratories Limited. USCA Case Number 2020-2137 (fms) |
| Aug 6, 2020 | 415 | USCA Notice of Docketing ROA (3) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [410] Notice of Appeal (Federal Circuit) filed by Fresenius Kabi USA, LLC. USCA Case Number 2020-2136 (fms) |
| Aug 5, 2020 | N/A | Description not available (0) Docket Text: Notification regarding [410] Notice of Appeal (Federal Circuit), [411] Notice of Appeal (Federal Circuit) sent to Reporter Gunning. (kmd) |
| Aug 5, 2020 | N/A | Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [410] Notice of Appeal (Federal Circuit), [411] Notice of Appeal (Federal Circuit). (kmd) |
| Aug 5, 2020 | 412 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Counsel - Shyamkrishna Palaiyanur by Mylan Laboratories Limited (Lennon, James) |
| Aug 4, 2020 | N/A | APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [409] Notice of Appeal (Federal Circuit) filed by Apotex Inc., Apotex Corp.. ( Filing fee $505, receipt number ADEDC-3106340.) (Tancredi, Damien) |
| Aug 4, 2020 | N/A | Description not available (0) Docket Text: Notification regarding [409] Notice of Appeal (Federal Circuit) sent to Reporter Gunning. (kmd) |
| Aug 4, 2020 | N/A | Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [409] Notice of Appeal (Federal Circuit). (kmd) |
| Aug 4, 2020 | N/A | APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [410] Notice of Appeal (Federal Circuit) filed by Fresenius Kabi USA, LLC. ( Filing fee $505, receipt number ADEDC-3107005.) (Farnan, Brian) |
| Aug 4, 2020 | N/A | APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [411] Notice of Appeal (Federal Circuit) filed by Mylan Laboratories Limited. ( Filing fee $505, receipt number ADEDC-3107038.) (Lennon, James) |
| Aug 4, 2020 | 409 | Notice of Appeal (Federal Circuit) (2) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [395] Order,, Set Deadlines, [406] Memorandum and Order, [394] Opinion, [407] Judgment . Appeal filed by Apotex Corp., Apotex Inc.. (Tancredi, Damien) |
| Aug 4, 2020 | 410 | Notice of Appeal (Federal Circuit) (2) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [395] Order,, Set Deadlines, [406] Memorandum and Order, [394] Opinion, [407] Judgment . Appeal filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Aug 4, 2020 | 411 | Notice of Appeal (Federal Circuit) (2) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [395] Order,, Set Deadlines, [406] Memorandum and Order, [394] Opinion, [407] Judgment . Appeal filed by Mylan Laboratories Limited. (Lennon, James) |
| Aug 4, 2020 | 411 | Notice of Appeal* (1) |
| Aug 4, 2020 | 410 | Notice of Appeal* (1) |
| Jul 6, 2020 | 406 | Memorandum and Order (6) Docket Text: MEMORANDUM.. Signed by Judge Colm F. Connolly on 7/6/2020. (fms) |
| Jul 6, 2020 | 407 | Judgment (6) Docket Text: FINAL JUDGMENT ORDER (CASE CLOSED). Signed by Judge Colm F. Connolly on 7/6/2020. (fms) |
| Jul 6, 2020 | 408 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,791,270 B2. (Attachments: # (1) Memorandum, # (2) Final Judgment)(fms) |
| Jul 6, 2020 | 408 | Memorandum (6) |
| Jul 6, 2020 | 408 | Final Judgment (6) |
| Jun 26, 2020 | 405 | Redacted Document (15) Docket Text: REDACTED VERSION of [403] Exhibit to a Document by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jun 20, 2020 | N/A | Bench Trial - Held (0) |
| Jun 20, 2020 | N/A | Bench Trial - Held (0) |
| Jun 20, 2020 | N/A | Bench Trial - Held (0) |
| Jun 20, 2020 | N/A | Bench Trial - Held (0) |
| Jun 20, 2020 | 292 | Motion to Preclude (2) |
| Jun 20, 2020 | 111 | Motion to Dismiss/Lack of Subject Jurisdiction (2) |
| Jun 20, 2020 | 109 | Motion to Stay (2) |
| Jun 20, 2020 | 31 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jun 20, 2020 | 1 | Complaint (11) |
| Jun 17, 2020 | 402 | Letter (4) |
| Jun 17, 2020 | 402 | Certificate of Compliance (1) |
| Jun 17, 2020 | 402 | Exhibit B (4) |
| Jun 17, 2020 | 402 | Exhibit C (4) |
| Jun 17, 2020 | 402 | Exhibit E (4) |
| Jun 17, 2020 | 402 | Exhibit F (5) |
| Jun 17, 2020 | 404 | Letter (5) Docket Text: Letter to The Honorable Colm F. Connolly from Michael J. Farnan regarding Judgment. (Farnan, Michael) |
| Jun 17, 2020 | 402 | Main Document (4) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding the Proposed Judgment - re Oral Order,. (Attachments: # (1) Certificate of Compliance, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit E, # (5) Exhibit F)(Hoeschen, Nathan) |
| Jun 10, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [401] Joint Letter to Hon. Colm F. Connolly from N. Hoeschen regarding Proposed Final Judgment Order. The parties may file letter briefs of no more than 700 words on or before June 17, 2020. Ordered by Judge Colm F. Connolly on 6/10/2020. (nmf) |
| Jun 9, 2020 | 401 | Letter (1) |
| Jun 9, 2020 | 401 | Exhibit Plaintiffs' proposed order (7) |
| Jun 9, 2020 | 401 | Exhibit Defendants' proposed order (5) |
| Jun 9, 2020 | 401 | Main Document (1) Docket Text: Joint Letter to Hon. Colm F. Connolly from N. Hoeschen regarding Proposed Final Judgment Order - re [395] Order,, Set Deadlines,. (Attachments: # (1) Exhibit Plaintiffs' proposed order, # (2) Exhibit Defendants' proposed order)(Hoeschen, Nathan) |
| Jun 5, 2020 | 400 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed order to June 9, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jun 3, 2020 | N/A | SO ORDERED (0) |
| Jun 2, 2020 | 399 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME Submit Proposed Final Judgment Order to June 5, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| May 27, 2020 | N/A | SO ORDERED (0) |
| May 26, 2020 | 398 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to extend deadline to submit final judgment to June 2, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| May 13, 2020 | N/A | SO ORDERED (0) |
| May 12, 2020 | 397 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to submit final judgment to May 26, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| May 5, 2020 | N/A | SO ORDERED (0) |
| May 5, 2020 | 396 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to EXTEND deadline for the parties to submit a proposed judgment to 5/12/2020 - filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Apr 29, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the Opinion at D.I. [394] has been replaced to correct the listed counsel for the parties. (nmf) |
| Apr 27, 2020 | 394 | Opinion (70) Docket Text: OPINION Signed by Judge Colm F. Connolly on 4/27/2020. (nmf) (Main Document 394 replaced on 4/29/2020) (nmf). |
| Apr 27, 2020 | 395 | Order (1) Docket Text: ORDER re [394] OPINION. IT IS HEREBY ORDERED that the parties shall submit no later than May 5, 2020 a proposed order by which the Court may enter final judgment consistent with the Opinion issued this day. ORDER, Setting Deadlines: Notice of Compliance deadline set for 5/5/2020. Signed by Judge Colm F. Connolly on 4/27/2020. (nmf) |
| Jan 13, 2020 | 393 | Exhibit List (6) |
| Jan 13, 2020 | 392 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Karen E. Keller - re [390] Notice (Other). (Keller, Karen) |
| Jan 13, 2020 | 393 | Letter to The Honorable Colm F. Connolly (1) |
| Jan 13, 2020 | 393 | Main Document (6) Docket Text: Exhibit List (Joint Post-Trial Submissions Exhibit List) by Cephalon, Inc.. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Hoeschen, Nathan) |
| Jan 10, 2020 | 390 | Notice (Other) (1) |
| Jan 10, 2020 | 389 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Karen E. Keller regarding correction to reply brief - re [377] Reply Brief. (Keller, Karen) |
| Jan 10, 2020 | 390 | Exhibit A (18) |
| Jan 10, 2020 | 391 | Letter (2) Docket Text: Letter to Honorable Colm F. Connolly from James Lennon regarding response to Plaintiff's Letter (D.I. 389). (Lennon, James) |
| Jan 10, 2020 | 390 | Main Document (1) Docket Text: NOTICE of Subsequent Federal Circuit Authority by Fresenius Kabi USA, LLC (Attachments: # (1) Exhibit A)(Farnan, Brian) |
| Jan 9, 2020 | 388 | Redacted Document (30) |
| Jan 9, 2020 | 386 | Redacted Document (30) Docket Text: REDACTED VERSION of [378] Opening Brief in Support by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Jan 9, 2020 | 387 | Redacted Document (30) Docket Text: REDACTED VERSION of [379] Statement Defendants' Findings of Fact (CORRECTED) by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Jan 9, 2020 | 388 | Exhibit A (105) |
| Jan 9, 2020 | 388 | Main Document (30) Docket Text: REDACTED VERSION of [380] Reply Brief by Fresenius Kabi USA, LLC. (Attachments: # (1) Exhibit A)(Farnan, Brian) |
| Jan 8, 2020 | 385 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Counsel Martha C. Kidd by Cephalon, Inc., Teva Pharmaceuticals International GmbH (Hoeschen, Nathan) |
| Jan 7, 2020 | 384 | Redacted Document (30) Docket Text: REDACTED VERSION of [377] Reply Brief by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Jan 6, 2020 | 383 | Redacted Document (13) Docket Text: REDACTED VERSION of [376] Reply Brief (Post-Trial Reply Brief) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jan 3, 2020 | 381 | Notice of Filing Multi Media Materials (3) Docket Text: NOTICE of filing the following Non-Paper material(s) in multi media format: Plaintiffs' and Defendants' Post-Trial Briefing (D.I. Nos. 360, 361, 370, 371, 376, 362, 363, 364, 369 & 377). Original Non-paper material(s) to be filed with the Clerk's Office. Notice filed by Karen Elizabeth Keller on behalf of Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH (Keller, Karen) |
| Jan 3, 2020 | N/A | Multi Media Document (0) Docket Text: [SEALED] MULTI MEDIA DOCUMENT in the form of a CD Rom containing e-briefs. Filing related to [381] Notice of Filing Multi Media Materials,. (Media on file in Clerk's Office). (fms) |
| Dec 27, 2019 | 375 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jeremy S. Cole as co-counsel. Reason for request: Leaving Firm. (Cole, Jeremy) |
| Dec 23, 2019 | 372 | Redacted Document (30) Docket Text: REDACTED VERSION of [371] POST Trial Brief of Validity (Responsive) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Dec 23, 2019 | 373 | Redacted Document (27) Docket Text: REDACTED VERSION of [370] POST Trial Brief, (in Response to Slayback's Opening Post-Trial Brief) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Dec 23, 2019 | 374 | Redacted Document (15) Docket Text: REDACTED VERSION of [369] POST Trial Brief by Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Dec 17, 2019 | N/A | CORRECTING ENTRY: (0) |
| Nov 5, 2019 | 365 | Redacted Document (30) Docket Text: REDACTED VERSION of [360] POST Trial Brief (Opening) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Nov 5, 2019 | 366 | Redacted Document (30) Docket Text: REDACTED VERSION of [361] Proposed Findings of Fact by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Nov 5, 2019 | 367 | Redacted Document (30) Docket Text: REDACTED VERSION of [363] POST Trial Brief by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Nov 5, 2019 | 368 | Redacted Document (30) Docket Text: REDACTED VERSION of [364] Proposed Findings of Fact by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Oct 31, 2019 | N/A | CORRECTING ENTRY: (0) |
| Oct 30, 2019 | N/A | CORRECTING ENTRY: (0) |
| Oct 29, 2019 | 358 | SO ORDERED (3) Docket Text: SO ORDERED, re [344] STIPULATION TO EXTEND TIME to file (i) Opening Post-Trial Briefs and Proposed Findings of Fact, (ii) Responsive Briefs; and (iii) Reply Briefs to (i) October 29, 2019, (ii) December 16, 2019, and (iii) December 30, 2019 filed by Fresenius Kabi USA, LLC. Signed by Judge Colm F. Connolly on 10/29/2019. (fms) |
| Oct 29, 2019 | 359 | SO ORDERED (10) Docket Text: SO ORDERED, re [345] Stipulation Admitting Trial Exhibits filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 10/29/2019. (fms) |
| Oct 29, 2019 | 362 | POST Trial Brief (10) Docket Text: POST TRIAL BRIEF Slayback Pharma LLC's Opening Post-Trial Brief by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Oct 25, 2019 | 345 | Stipulation (3) |
| Oct 25, 2019 | 345 | Exhibit A (7) |
| Oct 25, 2019 | 346 | Notice (Other) (2) |
| Oct 25, 2019 | 346 | PDX-1 (Siepmann Infringement Direct) (2) |
| Oct 25, 2019 | 346 | PDX-2 (Derendorf Direct) (7) |
| Oct 25, 2019 | 346 | PDX-2-7 (Derendorf Drawing) (2) |
| Oct 25, 2019 | 346 | PDX-2-8 (Derendorf Drawing) (2) |
| Oct 25, 2019 | 346 | PDX-3 (Leoni Direct) (9) |
| Oct 25, 2019 | 346 | PDX-4 (Anslyn Direct) (24) |
| Oct 25, 2019 | 346 | PDX-5 (Siepmann Validity Direct) (2) |
| Oct 25, 2019 | 346 | PDX-6 (Agarwal Direct) (5) |
| Oct 25, 2019 | 346 | PDX-7 (Jarosz Direct) (15) |
| Oct 25, 2019 | 346 | Direct Examination of Dr. Rodolfo Pinal (invalidity) (49) |
| Oct 25, 2019 | 346 | Direct Examination of Dr. John Yates (invalidity) (22) |
| Oct 25, 2019 | 346 | Direct Examination of Dr. Michael Thirman (invalidity) (37) |
| Oct 25, 2019 | 346 | Direct Examination of Mr. Robert Ruffolo (secondary considerations) (18) |
| Oct 25, 2019 | 346 | Direct Examination of Dr. Michael Thirman (secondary considerations) (2) |
| Oct 25, 2019 | 346 | Direct Examination of Dr. Jeffrey Stec (secondary considerations) (15) |
| Oct 25, 2019 | 347 | Notice (Other) (2) |
| Oct 25, 2019 | 347 | Plaintiffs' Opening Demonstratives (42) |
| Oct 25, 2019 | 347 | Plaintiffs' Closing Demonstratives (177) |
| Oct 25, 2019 | 348 | Transcript (324) Docket Text: Official Transcript of bench trial held on September 9, 2019 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning, Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/15/2019. Redacted Transcript Deadline set for 11/25/2019. Release of Transcript Restriction set for 1/23/2020. (vjg) |
| Oct 25, 2019 | 349 | Transcript (343) Docket Text: Official Transcript of bench trial held on September 10, 2019 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning, Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/15/2019. Redacted Transcript Deadline set for 11/25/2019. Release of Transcript Restriction set for 1/23/2020. (vjg) |
| Oct 25, 2019 | 350 | Transcript (281) Docket Text: Official Transcript of bench trial held on September 11, 2019 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning, Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/15/2019. Redacted Transcript Deadline set for 11/25/2019. Release of Transcript Restriction set for 1/23/2020. (vjg) |
| Oct 25, 2019 | 351 | Transcript (266) Docket Text: Official Transcript of bench trial held on September 12, 2019 before Judge Connolly. Court Reporter/Transcriber Valerie Gunning, Valerie_Gunning@ded.uscourts.gov. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/15/2019. Redacted Transcript Deadline set for 11/25/2019. Release of Transcript Restriction set for 1/23/2020. (vjg) |
| Oct 25, 2019 | 345 | Main Document (3) Docket Text: STIPULATION and [Proposed Order] Admitting Trial Exhibits by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # (1) Exhibit A)(Hoeschen, Nathan) |
| Oct 25, 2019 | 346 | Main Document (2) Docket Text: NOTICE of Lodging of Trial Demonstratives by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH (Attachments: # (1) PDX-1 (Siepmann Infringement Direct), # (2) PDX-2 (Derendorf Direct), # (3) PDX-2-7 (Derendorf Drawing), # (4) PDX-2-8 (Derendorf Drawing), # (5) PDX-3 (Leoni Direct), # (6) PDX-4 (Anslyn Direct), # (7) PDX-5 (Siepmann Validity Direct), # (8) PDX-6 (Agarwal Direct), # (9) PDX-7 (Jarosz Direct), # (10) Direct Examination of Dr. Rodolfo Pinal (invalidity), # (11) Direct Examination of Dr. John Yates (invalidity), # (12) Direct Examination of Dr. Michael Thirman (invalidity), # (13) Direct Examination of Mr. Robert Ruffolo (secondary considerations), # (14) Direct Examination of Dr. Michael Thirman (secondary considerations), # (15) Direct Examination of Dr. Jeffrey Stec (secondary considerations))(Hoeschen, Nathan) |
| Oct 25, 2019 | 347 | Main Document (2) Docket Text: NOTICE of Lodging of Plaintiffs' Trial Demonstratives by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH (Attachments: # (1) Plaintiffs' Opening Demonstratives, # (2) Plaintiffs' Closing Demonstratives)(Hoeschen, Nathan) |
| Oct 20, 2019 | 344 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to file (i) Opening Post-Trial Briefs and Proposed Findings of Fact, (ii) Responsive Briefs; and (iii) Reply Briefs to (i) October 29, 2019, (ii) December 16, 2019, and (iii) December 30, 2019 - filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Oct 16, 2019 | N/A | CORRECTING ENTRY: (0) |
| Oct 15, 2019 | 341 | Redacted Document (8) |
| Oct 15, 2019 | 341 | Exhibit 1 (1) |
| Oct 15, 2019 | 341 | Exhibit 2 (1) |
| Oct 15, 2019 | 341 | Exhibit 3 (1) |
| Oct 15, 2019 | 341 | Exhibit 4 (1) |
| Oct 15, 2019 | 341 | Exhibit 5 (1) |
| Oct 15, 2019 | 341 | Certification (1) |
| Oct 15, 2019 | 341 | Certificate of Service (1) |
| Oct 15, 2019 | 342 | Redacted Document (4) Docket Text: REDACTED VERSION of [338] Letter to the Honorable Colm F. Connolly from Nathan Hoeschen by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Oct 15, 2019 | 343 | Redacted Document (14) Docket Text: REDACTED VERSION of [339] MEMORANDUM in Support, of the Admission of Dr. Praveen Subbappa's Deposition Testimony by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) (Main Document 343 replaced on 10/16/2019) (fms). |
| Oct 15, 2019 | 341 | Main Document (8) Docket Text: REDACTED VERSION of [340] Statement, by Slayback Pharma Limited Liability Company. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Certification, # (7) Certificate of Service)(Ormerod, Eve) |
| Sep 30, 2019 | 337 | SO ORDERED (2) Docket Text: SO ORDERED, re [336] Stipulation and Order Regarding the Deposition Testimony of Dr. Subbappa filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 9/30/2019. (fms) |
| Sep 26, 2019 | 336 | Stipulation (2) Docket Text: STIPULATION [and Proposed Order] Regarding the Deposition Testimony of Dr. Subbappa by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Sep 24, 2019 | 334 | Redacted Document (10) Docket Text: REDACTED VERSION of [332] Statement Plaintiffs' Timeline by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Sep 24, 2019 | 335 | Redacted Document (4) Docket Text: REDACTED VERSION of [333] Statement Defendants' Timeline of Events by Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Sep 19, 2019 | N/A | Bench Trial - Completed (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial completed on 9/19/2019. (Court Reporter V. Gunning.) (DAY 7) (fms) |
| Sep 18, 2019 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 9/18/2019. (Court Reporter V. Gunning.)(DAY 6) (fms) |
| Sep 17, 2019 | 331 | Letter (2) |
| Sep 17, 2019 | 331 | Exhibit A (4) |
| Sep 17, 2019 | 331 | Main Document (2) Docket Text: Letter to The Honorable Colm F. Connolly from Karen E. Keller regarding Dr. Siepmann Trial Exhibits - re [330] Letter. (Attachments: # (1) Exhibit A)(Keller, Karen) |
| Sep 16, 2019 | 327 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Karen E. Keller regarding Plaintiffs' Position on the Relevance of Evidence Relating to Objective Indicia of Non-Obviousness. (Keller, Karen) |
| Sep 16, 2019 | 328 | Redacted Document (30) Docket Text: REDACTED VERSION of [321] Letter by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Sep 16, 2019 | 329 | Redacted Document (5) Docket Text: REDACTED VERSION of [320] Stipulation by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Sep 16, 2019 | 330 | Letter (2) |
| Sep 16, 2019 | 330 | Exhibit A (5) |
| Sep 16, 2019 | 330 | Exhibit B (3) |
| Sep 16, 2019 | 330 | Exhibit C (4) |
| Sep 16, 2019 | 330 | Main Document (2) Docket Text: Letter to The Honorable Colm F. Connolly from Brian E. Farnan regarding Dr. Siepmann's Exhibits and Testimony. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Farnan, Brian) |
| Sep 11, 2019 | 326 | SO ORDERED (2) Docket Text: SO ORDERED, re [93] STIPULATION and Order of Partial Dismissal. Signed by Judge Colm F. Connolly on 9/11/2019. (nmf) |
| Sep 10, 2019 | 322 | SO ORDERED (3) Docket Text: SO ORDERED, re [312] STIPULATION (and proposed order) Regarding The Admissibility of Certain Documents Produced by Peter Grebow. Signed by Judge Colm F. Connolly on 9/9/2019. (nmf) |
| Sep 10, 2019 | 323 | SO ORDERED (3) Docket Text: SO ORDERED, re [319] STIPULATION [and Proposed Order] Regarding the Admissibility of Certain Documents Involving by Dr. Gerald Messerschmidt. Signed by Judge Colm F. Connolly on 9/9/2019. (nmf) |
| Sep 10, 2019 | 324 | SO ORDERED (2) Docket Text: SO ORDERED, re [318] Joint STIPULATION as to Slayback and Plaintiffs. Signed by Judge Colm F. Connolly on 9/9/2019. (nmf) |
| Sep 9, 2019 | N/A | CORRECTING ENTRY: (0) |
| Sep 9, 2019 | N/A | Bench Trial - Begun (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Bench Trial held on 9/9/2019. (Court Reporter V. Gunning.)(DAY 1) (nmf) |
| Sep 6, 2019 | 318 | Stipulation (2) Docket Text: Joint STIPULATION as to Slayback and Plaintiffs by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Sep 6, 2019 | 319 | Stipulation (3) Docket Text: STIPULATION [and Proposed Order] Regarding the Admissibility of Certain Documents Involving by Dr. Gerald Messerschmidt by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Sep 5, 2019 | 313 | Redacted Document (13) Docket Text: REDACTED VERSION of [306] Reply Brief in Support of Motion to Preclude Certain Expert Opinions of Dr. John Yates by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Sep 5, 2019 | 314 | Order on Motion to Preclude (2) Docket Text: ORDER denying without prejudice to renew at trial by specific objection [292] Motion to Preclude; denying without prejudice to renew at trial by specific objection [294] Motion to Preclude. Signed by Judge Colm F. Connolly on 9/5/2019. (nmf) |
| Sep 5, 2019 | 315 | Redacted Document (28) |
| Sep 5, 2019 | 315 | Exhibit 1 (41) |
| Sep 5, 2019 | 315 | Exhibit 2D (45) |
| Sep 5, 2019 | 315 | Exhibit 2P (37) |
| Sep 5, 2019 | 315 | Exhibit 3D (105) |
| Sep 5, 2019 | 315 | Exhibit 3P (95) |
| Sep 5, 2019 | 315 | Exhibit 4D (149) |
| Sep 5, 2019 | 315 | Exhibit 4P (40) |
| Sep 5, 2019 | 315 | Exhibit 5D (4) |
| Sep 5, 2019 | 315 | Exhibit 5D.1 (3) |
| Sep 5, 2019 | 315 | Exhibit 5D.2 (3) |
| Sep 5, 2019 | 315 | Exhibit 5P (5) |
| Sep 5, 2019 | 315 | Exhibit 5P.1 (4) |
| Sep 5, 2019 | 315 | Exhibit 5P.2 (42) |
| Sep 5, 2019 | 315 | Exhibit 6D (23) |
| Sep 5, 2019 | 315 | Exhibit 6P (35) |
| Sep 5, 2019 | 315 | Exhibit 7D (31) |
| Sep 5, 2019 | 315 | Exhibit 7P (31) |
| Sep 5, 2019 | 315 | Exhibit 8D (400) |
| Sep 5, 2019 | 315 | Exhibit 8P (607) |
| Sep 5, 2019 | 316 | Redacted Document (10) |
| Sep 5, 2019 | 316 | Exhibit A-B (1) |
| Sep 5, 2019 | 316 | Exhibit C-H (29) |
| Sep 5, 2019 | 315 | Main Document (28) Docket Text: REDACTED VERSION of [307] Proposed Pretrial Order,, by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2D, # (3) Exhibit 2P, # (4) Exhibit 3D, # (5) Exhibit 3P, # (6) Exhibit 4D, # (7) Exhibit 4P, # (8) Exhibit 5D, # (9) Exhibit 5D.1, # (10) Exhibit 5D.2, # (11) Exhibit 5P, # (12) Exhibit 5P.1, # (13) Exhibit 5P.2, # (14) Exhibit 6D, # (15) Exhibit 6P, # (16) Exhibit 7D, # (17) Exhibit 7P, # (18) Exhibit 8D, # (19) Exhibit 8P)(Hoeschen, Nathan) |
| Sep 5, 2019 | 316 | Main Document (10) Docket Text: REDACTED VERSION of [308] Reply Brief, - Defendants' Reply in Support of Daubert Motion to Exclude the Opinions and Testimony of Plaintiffs' Expert Mr. Jarosz by Mylan Laboratories Limited. (Attachments: # (1) Exhibit A-B, # (2) Exhibit C-H)(Lennon, James) |
| Sep 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alex Grabowski for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Sep 4, 2019 | N/A | Pretrial Conference - Final (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Final Pretrial Conference held on 9/4/2019. (Court Reporter V. Gunning.) (nmf) |
| Sep 3, 2019 | N/A | SO ORDERED (0) |
| Sep 3, 2019 | 312 | Stipulation (3) Docket Text: STIPULATION (and proposed order) Regarding The Admissibility of Certain Documents Produced by Peter Grebow by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Aug 30, 2019 | N/A | CORRECTING ENTRY: (0) |
| Aug 30, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 30, 2019 | 309 | Letter (1) |
| Aug 30, 2019 | 309 | Letter to the Court from Shyam Palaiyanur, Esq. (1) |
| Aug 30, 2019 | 310 | Redacted Document (30) Docket Text: REDACTED VERSION of [302] Reply Brief, Plaintiffs' Response to Defendants' Daubert Motion to Exclude the Opinions and Testimony of Plaintiffs' Expert Mr. Jarosz by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Aug 30, 2019 | 311 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alex Grabowski - filed by Eagle Pharmaceuticals, Inc.. (Keller, Karen) |
| Aug 30, 2019 | 309 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from James M. Lennon regarding submission of replacement of Defendants' Reply Daubert Brief - re CORRECTING ENTRY:, [308] Reply Brief,. (Attachments: # (1) Letter to the Court from Shyam Palaiyanur, Esq.)(Lennon, James) |
| Aug 29, 2019 | N/A | SO ORDERED (0) |
| Aug 29, 2019 | N/A | SO ORDERED (0) |
| Aug 29, 2019 | 305 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Rhyea Malik - filed by Mylan Laboratories Limited. (Lennon, James) |
| Aug 28, 2019 | 304 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME Reply Briefs in Support of Daubert Motions to 8/28/19 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Aug 27, 2019 | N/A | SO ORDERED (0) |
| Aug 27, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 26, 2019 | 303 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David S. Steuer - filed by Mylan Laboratories Limited. (Lennon, James) |
| Aug 22, 2019 | N/A | CORRECTING ENTRY: (0) |
| Aug 16, 2019 | 299 | Redacted Document (11) |
| Aug 16, 2019 | 299 | Exhibit A (8) |
| Aug 16, 2019 | 299 | Exhibit B (8) |
| Aug 16, 2019 | 299 | Exhibit C (11) |
| Aug 16, 2019 | 299 | Exhibit D (61) |
| Aug 16, 2019 | 299 | Exhibit E (2) |
| Aug 16, 2019 | 299 | Text of Proposed Order (1) |
| Aug 16, 2019 | 300 | Redacted Document (30) Docket Text: REDACTED VERSION of [293] Opening Brief in Support, by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Aug 16, 2019 | 299 | Main Document (11) Docket Text: REDACTED VERSION of [294] MOTION to Preclude - Defendants' Daubert Motion to Exclude the Opinions and Testimony of Plaintiffs' Expert Mr. Jarosz by Mylan Laboratories Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Text of Proposed Order)(Lennon, James) |
| Aug 13, 2019 | 298 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Appearance by Mylan Laboratories Limited of Bobby Delafield and Anjali Deshmukh (Lennon, James) |
| Aug 12, 2019 | 297 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Notice pursuant to 35 U.S.C.§ 282 filed by Apotex Corp., Apotex Inc., Fresenius Kabi USA, LLC, Mylan Laboratories Limited, Slayback Pharma Limited Liability Company.(Cole, Jeremy) |
| Aug 9, 2019 | N/A | SO ORDERED (0) |
| Aug 9, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 9, 2019 | 295 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Matthew L. Lachman - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Aug 9, 2019 | 296 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from James Lennon. (Lennon, James) |
| Aug 8, 2019 | 291 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen. (Hoeschen, Nathan) |
| Aug 8, 2019 | 292 | Text of Proposed Order (1) |
| Aug 8, 2019 | 292 | Main Document (2) Docket Text: MOTION to Preclude Certain Expert Opinions of Dr. John Yates - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # (1) Text of Proposed Order)(Hoeschen, Nathan) |
| Aug 7, 2019 | 290 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian E. Farnan regarding Withdrawal of Request to Adjust Trial Schedule. (Farnan, Brian) |
| Aug 5, 2019 | 289 | Letter (2) |
| Aug 5, 2019 | 289 | Exhibit A (5) |
| Aug 5, 2019 | 289 | Main Document (2) Docket Text: Letter to The Honorable Colm F. Connolly from Karen E. Keller regarding Defendants letter to the Court Requesting to Adjust Trial Schedule - re [288] Letter. (Attachments: # (1) Exhibit A)(Keller, Karen) |
| Aug 2, 2019 | 288 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian E. Farnan regarding Request to Adjust Trial Schedule. (Farnan, Brian) |
| Aug 1, 2019 | 287 | Memorandum and Order (3) Docket Text: MEMORANDUM ORDER granting [271] MOTION for Judgment on the Pleadings on Apotex's Twenty-Eighth Additional Defense Pursuant to Fed. R. Civ. P. 12(c) and 12(h) filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 8/1/2019. (nmf) |
| Jun 28, 2019 | 286 | Redacted Document (1) |
| Jun 28, 2019 | 286 | Opposition Brief-Redacted (15) |
| Jun 28, 2019 | 286 | Exhibit 1 (43) |
| Jun 28, 2019 | 286 | Exhibit 2 (2) |
| Jun 28, 2019 | 286 | Exhibit 3 (2) |
| Jun 28, 2019 | 286 | Exhibit 4 (2) |
| Jun 28, 2019 | 286 | Main Document (1) Docket Text: REDACTED VERSION of [279] Answering Brief in Opposition, by Apotex Corp., Apotex Inc.. (Attachments: # (1) Opposition Brief-Redacted, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4)(Cole, Jeremy) |
| Jun 27, 2019 | 285 | Redacted Document (30) Docket Text: REDACTED VERSION of [283] Reply Brief, by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jun 26, 2019 | 284 | Redacted Document (30) Docket Text: REDACTED VERSION of [281] Joint MOTION to Redact [269] Transcript, (to Redact Portions of the May 16, 2019 Hearing Transcript) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jun 21, 2019 | N/A | Oral Order (0) |
| Jun 20, 2019 | 282 | Letter (1) |
| Jun 20, 2019 | 282 | Amended Opening Brief in Support of Plaintiffs' Motion for Judgment on the (21) |
| Jun 20, 2019 | 282 | Exhibit A-J to Amended Opening Brief (42) |
| Jun 20, 2019 | 282 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Karen E. Keller regarding amended version of Plaintiffs' Opening Brief in Support of Plaintiffs Motion for Judgment on the Pleadings (D.I. 272) to comply with the Court's updated rules - re [272] Opening Brief in Support,. (Attachments: # (1) Amended Opening Brief in Support of Plaintiffs' Motion for Judgment on the Pleadings, # (2) Exhibit A-J to Amended Opening Brief)(Keller, Karen) |
| Jun 18, 2019 | 280 | Redacted Document (20) |
| Jun 18, 2019 | 280 | Exhibit A-J (19) |
| Jun 18, 2019 | 280 | Main Document (20) Docket Text: REDACTED VERSION of [272] Opening Brief in Support, (MOTION for Judgment on the Pleadings on Apotex's Twenty-Eighth Additional Defense Pursuant to Fed. R. Civ. P. 12(c) and 12(h)) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # (1) Exhibit A-J)(Keller, Karen) |
| Jun 10, 2019 | 278 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Reply Expert Report of Dr. Michael J. Thirman, MD Responsive to Objective Indicia of Nonobviousness and (ii) Reply Expert Report of Dr. Rodolfo Pinal Responsive to Objective Indicia of Nonobviousness filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Jun 7, 2019 | 276 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Report of John Yates, M.D. Responsive to Secondary Considerations filed by Apotex Corp., Apotex Inc., Slayback Pharma Limited Liability Company.(Cole, Jeremy) |
| Jun 7, 2019 | 277 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Reply Expert Report of George M. Grass, Pharm.D., Ph.D.; (2) Responsive Expert Report of Robert Ruffolo, Ph.D.; and (3) Rebuttal Expert Report of Jeffery A. Stec, Ph.D. filed by Mylan Laboratories Limited.(Lennon, James) |
| Jun 5, 2019 | N/A | SO ORDERED (0) |
| Jun 5, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jun 5, 2019 | 275 | Disclosure Statement (1) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc., Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc.. (Keller, Karen) |
| Jun 4, 2019 | 274 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney John D. Cravero - filed by Apotex Corp., Apotex Inc.. (Cole, Jeremy) |
| May 31, 2019 | 273 | Notice of Intent to Request Transcript Redaction (2) Docket Text: NOTICE of Intent to Request Redaction by David M. Fry re [269] Transcript, (Fry, David) |
| May 30, 2019 | 271 | Motion for Judgment on the Pleadings (3) Docket Text: MOTION for Judgment on the Pleadings on Apotex's Twenty-Eighth Additional Defense Pursuant to Fed. R. Civ. P. 12(c) and 12(h) - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| May 29, 2019 | 270 | Notice of Intent to Request Transcript Redaction (2) Docket Text: NOTICE of Intent to Request Redaction by Jeremy S. Cole re [269] Transcript, (Cole, Jeremy) |
| May 28, 2019 | N/A | SO ORDERED (0) |
| May 24, 2019 | 268 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for all defendants to file Reply Expert Reports Limited to Responses on Objective Indicia of Non-Obviousness to June 5, 2019 - filed by Mylan Laboratories Limited. (Lennon, James) Modified on 5/28/2019 (fms). |
| May 21, 2019 | 267 | Redacted Document (5) |
| May 21, 2019 | 267 | Exhibit A (7) |
| May 21, 2019 | 267 | Exhibit B (6) |
| May 21, 2019 | 267 | Exhibit C (21) |
| May 21, 2019 | 267 | Exhibit D (5) |
| May 21, 2019 | 267 | Exhibit E (44) |
| May 21, 2019 | 267 | Exhibit F (6) |
| May 21, 2019 | 267 | Main Document (5) Docket Text: REDACTED VERSION of [261] Letter, by Mylan Laboratories Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(Lennon, James) |
| May 20, 2019 | 263 | Redacted Document (2) Docket Text: REDACTED VERSION of [258] MOTION for Discovery Conference by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| May 20, 2019 | 264 | Redacted Document (3) |
| May 20, 2019 | 264 | Exhibits A-L (44) |
| May 20, 2019 | 264 | Text of Proposed Order (1) |
| May 20, 2019 | 264 | Certification of Counsel (1) |
| May 20, 2019 | 265 | Redacted Document (30) Docket Text: REDACTED VERSION of [260] Letter by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| May 20, 2019 | 266 | Redacted Document (21) Docket Text: REDACTED VERSION of [262] Letter by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| May 20, 2019 | 264 | Main Document (3) Docket Text: REDACTED VERSION of [259] Letter, by Fresenius Kabi USA, LLC. (Attachments: # (1) Exhibits A-L, # (2) Text of Proposed Order, # (3) Certification of Counsel)(Farnan, Brian) |
| May 16, 2019 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 5/16/2019. (Court Reporter V. Gunning.) (nmf) |
| May 3, 2019 | 257 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Non-Infringement Report of John Yates, M.D. filed by Apotex Corp., Apotex Inc., Slayback Pharma Limited Liability Company.(Cole, Jeremy) |
| May 2, 2019 | 255 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Expert Report of Ashwani K. Agarwal, M.D. Concerning Validity, (2) Responsive Expert Report of Dr. Eric V. Anslyn, Ph.D., (3) Expert Report of Hartmut Derendorf, Ph.D., (4) Expert Report of John C. Jarosz, (5) Responsive Expert Report of Jeffrey D. Kittendorf, Ph.D. (6), Expert Report of Lorenzo Leoni, Ph.D., (7) Responsive Expert Report of Juergen Siepmann, Ph.D. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| May 2, 2019 | 256 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Responsive Noninfringement Report of Dr. Rodolfo Pinal and (ii) Responsive Noninfringement Report of Michael Thirman, MD filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Apr 30, 2019 | 254 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff Eagle Pharmaceuticals, Inc.'s Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(A) filed by Eagle Pharmaceuticals, Inc..(Keller, Karen) |
| Apr 25, 2019 | 253 | SO ORDERED (3) Docket Text: SO ORDERED, re [252] Stipulation filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Setting Deadlines: Expert Discovery completed by 7/12/2019. See Stipulation for further details and deadlines. Signed by Judge Colm F. Connolly on 4/25/2019. (fms) |
| Apr 23, 2019 | 252 | Stipulation (3) Docket Text: STIPULATION (and proposed order) to extend case deadlines by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Apr 22, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Set/Reset Hearings: A Discovery Conference is set per request of counsel for 5/16/2019 at 03:30 PM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
| Apr 15, 2019 | 251 | Notice (Other) (2) Docket Text: NOTICE of Change of Firm Affiliation - Constance S. Huttner, Frank D. Rodriguez, James P. Barabas, and Beth C. Finkelstein by Slayback Pharma Limited Liability Company (Ormerod, Eve) |
| Apr 8, 2019 | 250 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Supplemental Expert Report of Jeffery D. Kittendorf, Ph.D. (2) Supplemental Expert Report of Juergen Siepmann, Ph.D. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Mar 27, 2019 | 249 | Notice of Appearance (1) |
| Mar 27, 2019 | 249 | Certificate of Service (1) |
| Mar 27, 2019 | 249 | Main Document (1) Docket Text: NOTICE of Appearance by Damien Nicholas Tancredi on behalf of Apotex Corp., Apotex Inc. (Attachments: # (1) Certificate of Service)(Tancredi, Damien) |
| Mar 15, 2019 | 247 | Redacted Document (7) Docket Text: REDACTED VERSION of [245] Letter, by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Mar 15, 2019 | 248 | Redacted Document (5) |
| Mar 15, 2019 | 248 | Exhibit A (4) |
| Mar 15, 2019 | 248 | Exhibit B (2) |
| Mar 15, 2019 | 248 | Exhibit C (2) |
| Mar 15, 2019 | 248 | Exhibit D (4) |
| Mar 15, 2019 | 248 | Exhibit E (2) |
| Mar 15, 2019 | 248 | Main Document (5) Docket Text: REDACTED VERSION of [244] Letter, by Mylan Laboratories Limited. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E)(Lennon, James) |
| Mar 14, 2019 | 246 | Redacted Document (26) Docket Text: REDACTED VERSION of [243] Letter, by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Mar 12, 2019 | N/A | Discovery Conference (0) |
| Mar 7, 2019 | 242 | Letter (6) |
| Mar 7, 2019 | 242 | Exhibit A (7) |
| Mar 7, 2019 | 242 | Exhibit B (3) |
| Mar 7, 2019 | 242 | Exhibit C (4) |
| Mar 7, 2019 | 242 | Exhibit D (17) |
| Mar 7, 2019 | 242 | Exhibit E (8) |
| Mar 7, 2019 | 242 | Exhibit F (5) |
| Mar 7, 2019 | 242 | Text of Proposed Order (1) |
| Mar 7, 2019 | 242 | Main Document (6) Docket Text: Letter to Honorable Colm F. Connolly from James Michael Lennon regarding Regarding Discovery Dispute. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Text of Proposed Order)(Lennon, James) |
| Mar 6, 2019 | N/A | SO ORDERED (0) |
| Mar 6, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Mar 5, 2019 | 241 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey A. Cohen - filed by Apotex Corp., Apotex Inc.. (Cole, Jeremy) |
| Feb 28, 2019 | 237 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Opening Expert Reports of Dr. Rodolfo Pinal and Michael J. Thirman, MD filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Feb 28, 2019 | 238 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Opening Expert Report of Dr. Rodolfo Pinal and Opening Expert Report of Michael J. Thirman, M.D. filed by Mylan Laboratories Limited.(Lennon, James) |
| Feb 28, 2019 | 239 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Expert Report of Ashwani K. Agarwal, M.D. Concerning Infringement (2) Expert Report of Dr. Jeffrey D. Kittendorf, Ph.D. (3) Expert Report of Juergen Siepmann, Ph.D. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Feb 28, 2019 | 240 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Opening Expert Report of John Yates, M.D. filed by Apotex Corp., Apotex Inc., Slayback Pharma Limited Liability Company.(Cole, Jeremy) |
| Feb 9, 2019 | 236 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Final Invalidity Contentions filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Feb 8, 2019 | 233 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Fourth Supplemental Responses and Objections to Defendants' First Set of Joint Interrogatories (Nos. 1-7) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Feb 8, 2019 | 234 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendant Slayback Pharma Limited Liability Company's First Supplemental Response to Plaintiffs' First Set of Interrogatories (Nos. 9-12) filed by Slayback Pharma Limited Liability Company.(Ormerod, Eve) |
| Feb 8, 2019 | 235 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Fresenius Kabi USA, LLC's First Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Feb 4, 2019 | N/A | Set/Reset Hearings (0) |
| Jan 31, 2019 | 231 | Notice (Other) (1) Docket Text: NOTICE of of Withdrawal/Entry of Appearance of Counsel by Apotex Corp., Apotex Inc. (Phillips, John) |
| Jan 31, 2019 | 232 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Final Infringement Contentions for Apotex Inc. and Apotex Corp. (2) Plaintiffs' Final Infringement Contentions for Mylan Laboratories Ltd. (3) Plaintiffs' Final Infringement Contentions for Fresenius Kabi USA, LLC (4) Plaintiffs' Final Infringement Contentions for Slayback Pharma Limited Liability Co. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Jan 22, 2019 | 230 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Mylan's Objections and Responses to Plaintiffs' First Set of Requests for Admission to Defendant Mylan Laboratories Ltd. (Request Nos. 1-61) filed by Mylan Laboratories Limited.(Lennon, James) |
| Jan 18, 2019 | 228 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Fresenius Kabi USA, LLC's Objections and Responses to Plaintiffs' First Set of Requests for Admissions (Nos. 1-61) filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Jan 18, 2019 | 229 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendant Slayback Pharma Limited Liability Co.'s Responses and Objections to Plaintiffs' First Set of Requests for Admission filed by Slayback Pharma Limited Liability Company.(Ormerod, Eve) |
| Jan 11, 2019 | 227 | Redacted Document (5) Docket Text: REDACTED VERSION of [220] Proposed Consent Judgment by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jan 8, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jan 7, 2019 | N/A | SO ORDERED (0) |
| Jan 7, 2019 | 225 | Stipulation (4) Docket Text: STIPULATION and Proposed Order to Consolidate by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Jan 7, 2019 | 226 | SO ORDERED (4) Docket Text: SO ORDERED, re (15 in 1:18-cv-01586-CFC, 225 in 1:17-cv-01154-CFC) STIPULATION AND ORDER TO CONSOLIDATE. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 17-1154-CFC ONLY. Signed by Judge Colm F. Connolly on 1/7/2019. Associated Cases: 1:17-cv-01154-CFC, 1:18-cv-01586-CFC(nmf) |
| Jan 4, 2019 | N/A | Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # [216] [SEALED] STIPULATION TO EXTEND TIME to file an Answering Brief and Reply Brief to Plaintiff's Motion. (fms) |
| Jan 4, 2019 | N/A | Remark (0) Docket Text: The 2/5/2019 Markman hearing is cancelled per D.I. [223]. (nmf) |
| Jan 4, 2019 | 222 | Redacted Document (3) Docket Text: REDACTED VERSION of [216] STIPULATION TO EXTEND TIME to file an Answering Brief and Reply Brief to Plaintiff's Motion to Dismiss for Lack of Jurisdiction Over the Subject Matter to January 11, 2019 and February 8, 2019 by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jan 4, 2019 | 223 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding the February 5, 2019 Claim Construction Hearing. (Hoeschen, Nathan) |
| Jan 4, 2019 | 224 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Anjali Deshmukh - filed by Mylan Laboratories Limited. (Lennon, James) |
| Jan 3, 2019 | 218 | Notice (Other) (5) Docket Text: NOTICE of Subpoena Directed to Hiren Patel by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH (Hoeschen, Nathan) |
| Jan 3, 2019 | 219 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Grebow's Objections and Responses to Defendants' Subpoenas filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Dec 26, 2018 | 217 | Redacted Document (24) Docket Text: REDACTED VERSION of [215] Notice (Other) by Apotex Corp., Apotex Inc.. (Phillips, John) |
| Dec 20, 2018 | N/A | SO ORDERED (0) |
| Dec 12, 2018 | 214 | Redacted Document (9) Docket Text: REDACTED VERSION of [208] Letter by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 11, 2018 | 213 | Redacted Document (5) |
| Dec 11, 2018 | 213 | Exhibit A (8) |
| Dec 11, 2018 | 213 | Certification (1) |
| Dec 11, 2018 | 213 | Text of Proposed Order (1) |
| Dec 11, 2018 | 213 | Main Document (5) Docket Text: REDACTED VERSION of [206] Letter by Fresenius Kabi USA, LLC. (Attachments: # (1) Exhibit A, # (2) Certification, # (3) Text of Proposed Order)(Farnan, Brian) |
| Dec 10, 2018 | 211 | SO ORDERED (4) Docket Text: SO ORDERED, re [210] STIPULATION TO EXTEND TIME. Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 1/18/2019., Expert Discovery due by 6/28/2019. See order for further details and deadlines. Signed by Judge Colm F. Connolly on 12/10/2018. (nmf) |
| Dec 10, 2018 | 212 | Notice (Other) (5) Docket Text: NOTICE of Subpoena Directed to Prasanna Sagar by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH (Hoeschen, Nathan) |
| Dec 7, 2018 | 210 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME [Various Deadlines - See Stipulation] to [Various Dates - See Stipulation] - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 6, 2018 | N/A | Remark (0) |
| Dec 4, 2018 | 207 | Scheduling Order (9) Docket Text: SCHEDULING ORDER: Discovery due by 12/21/2018. Joint Claim Construction Brief due by 1/18/2019. A Markman Hearing is set for 2/5/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 9/4/2019 at 01:30 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 9/9/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 12/4/2018. (nmf) |
| Nov 30, 2018 | N/A | Remark (0) |
| Nov 30, 2018 | 204 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Teva Pharmaceuticals International GmbH, and Cephalon, Inc.'s Responses and Objections to Defendants Apotex Inc.'s and Apotex Corp.'s First Requests for Production of Documents and Things to Plaintiffs (Nos. 1-25) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Nov 30, 2018 | 205 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Eagle Pharmaceuticals, Inc.s Responses and Objections to Defendants Apotex Inc.s and Apotex Corp.s First Requests for Production of Documents and Things to Plaintiffs (Nos. 1-25) filed by Eagle Pharmaceuticals, Inc..(Keller, Karen) |
| Nov 29, 2018 | N/A | Oral Order (0) |
| Nov 29, 2018 | 203 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Third Supplemental Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1, 5) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Nov 28, 2018 | 202 | Proposed Order (9) Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Nov 27, 2018 | N/A | Set/Reset Hearings (0) |
| Nov 26, 2018 | 201 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Anthony Drager on 11/29/2018 filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Nov 20, 2018 | N/A | Oral Order (0) |
| Nov 20, 2018 | 200 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Responses and Objections to Defendants' First Set of Joint Interrogatories (Nos. 1, 5) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Nov 16, 2018 | 197 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of SUBRAMANIAN NARAYANASWAMY on January 10, 2019 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Nov 16, 2018 | 198 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of KATIE REED on December 4, 2018 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Nov 14, 2018 | 195 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of 1) Steven Krill's Objections and Responses to Defendants' Subpoena; 2) Salamandra LLC's Objections and Responses to Defendants' Subpoena; 3) Transpharmative Advisors LLC's Objections and Responses to Defendants' Subpoena; and 4) Leonore C. Witchey-Lakshmanan's Objections and Responses to Defendants' Subpoenas filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Nov 14, 2018 | 196 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Rachel LaBell's Objections and Responses to Apotex's Subpoenas filed by Rachel Labell.(Hoeschen, Nathan) |
| Nov 9, 2018 | 192 | Redacted Document (6) |
| Nov 9, 2018 | 194 | Proposed Order (8) |
| Nov 9, 2018 | 192 | Exhibit A (1) |
| Nov 9, 2018 | 192 | Exhibit B (1) |
| Nov 9, 2018 | 193 | Redacted Document (3) Docket Text: REDACTED VERSION of [180] Declaration, by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Nov 9, 2018 | 194 | Exhibit A (1) |
| Nov 9, 2018 | 192 | Main Document (6) Docket Text: REDACTED VERSION of [178] MOTION to Seal and Redact Limited Portions of The October 19, 2018 Telephone Conference Transcript by Defendant Slayback (Unopposed); along with Certificate of Service by Slayback Pharma Limited Liability Company. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Ormerod, Eve) |
| Nov 9, 2018 | 194 | Main Document (8) Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # (1) Exhibit A)(Hoeschen, Nathan) |
| Nov 8, 2018 | N/A | SO ORDERED (0) |
| Nov 8, 2018 | 189 | Redacted Document (1) |
| Nov 8, 2018 | 190 | Redacted Document (1) |
| Nov 8, 2018 | 191 | Redacted Document (2) |
| Nov 8, 2018 | 189 | Exhibit 1 (14) |
| Nov 8, 2018 | 190 | Exhibit 1 (14) |
| Nov 8, 2018 | 191 | Exhibits 1-2 (22) |
| Nov 8, 2018 | 189 | Main Document (1) Docket Text: REDACTED VERSION of [169] Notice (Other) by Apotex Corp., Apotex Inc.. (Attachments: # (1) Exhibit 1)(Phillips, John) |
| Nov 8, 2018 | 190 | Main Document (1) Docket Text: REDACTED VERSION of [170] Notice (Other) by Apotex Corp., Apotex Inc.. (Attachments: # (1) Exhibit 1)(Phillips, John) |
| Nov 8, 2018 | 191 | Main Document (2) Docket Text: REDACTED VERSION of [171] Notice (Other) by Apotex Corp., Apotex Inc.. (Attachments: # (1) Exhibits 1-2)(Phillips, John) |
| Nov 7, 2018 | 188 | Redacted Document (2) |
| Nov 7, 2018 | N/A | Set/Reset Transcript Deadlines (0) Docket Text: Set Transcript Deadlines re [187] Redacted Transcript. Release of Transcript Restriction set for 2/5/2019. (fms) |
| Nov 7, 2018 | 183 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Aden Allen - filed by Mylan Laboratories Limited. (Lennon, James) |
| Nov 7, 2018 | 184 | Order on Motion to Seal (2) Docket Text: ORDER granting [178] Unopposed Motion to Seal and Redact Limited Portions of the October 19, 2018 Telephone Conference Transcript. Signed by Judge Colm F. Connolly on 11/7/2018. (fms) |
| Nov 7, 2018 | 186 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.s Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Nov 7, 2018 | 187 | Redacted Transcript (10) Docket Text: Redaction of [185] SEALED Transcript. (fms) |
| Nov 7, 2018 | 188 | Exhibit 1 (18) |
| Nov 7, 2018 | 188 | Main Document (2) Docket Text: REDACTED VERSION of [177] Notice (Other) by Fresenius Kabi USA, LLC. (Attachments: # (1) Exhibit 1)(Farnan, Brian) |
| Nov 6, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Nov 5, 2018 | 181 | Order (2) Docket Text: ORDER, IT IS ORDERED that, on or before November 9, 2018, the Plaintiffs shall submit a proposed revised scheduling order that comports with the Court's "Rule 16 Scheduling Order for Patent Cases" (revised on October 9, 2018), available on the Court's website. Plaintiffs shall also email the Court a Word version of the proposed revised scheduling order via the Court's civil email address at cfc civil@.ded.uscourts.gov. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 11/9/2018.) See order for further details and dates. Signed by Judge Colm F. Connolly on 11/5/2018. (nmf) |
| Nov 5, 2018 | 182 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendant Slayback Pharma Limited Liability Co.'s Responses and Objections to Plaintiffs' Notice of Rule 30(b)(6) Deposition of Defendant Slayback Pharma Limited Liability Co. filed by Slayback Pharma Limited Liability Company.(Ormerod, Eve) |
| Nov 2, 2018 | 179 | Proposed Order (2) Docket Text: PROPOSED ORDER re [178] MOTION to Seal and Redact Limited Portions of The October 19, 2018 Telephone Conference Transcript by Defendant Slayback (Unopposed); along with Certificate of Service by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Nov 1, 2018 | N/A | CORRECTING ENTRY: (0) |
| Oct 31, 2018 | 168 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex Inc.'s and Apotex Corp.'s First Requests for Production of Documents and Things to Plaintiffs Teva Pharmaceuticals International GmbH, Cephalon, Inc. and Eagle Pharmaceuticals, Inc. filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
| Oct 31, 2018 | 172 | Notice (Other) (2) |
| Oct 31, 2018 | 172 | Exhibits 1-2 (17) |
| Oct 31, 2018 | 173 | Notice (Other) (2) |
| Oct 31, 2018 | 173 | Exhibit 1 (4) |
| Oct 31, 2018 | 174 | Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Cephalon, Inc. and Teva Pharmaceuticals International GmbH on 12/18/2018 filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Oct 31, 2018 | 175 | Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Eagle Pharmaceuticals, Inc. on 12/20/2018 filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Oct 31, 2018 | 176 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Steven Krill on 11/29/2018 filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Oct 31, 2018 | 172 | Main Document (2) Docket Text: NOTICE of Subpoenas to Rachel LaBell by Apotex Corp., Apotex Inc. (Attachments: # (1) Exhibits 1-2)(Phillips, John) |
| Oct 31, 2018 | 173 | Main Document (2) Docket Text: NOTICE of Subpoena to Christina Jordan by Apotex Corp., Apotex Inc. (Attachments: # (1) Exhibit 1)(Phillips, John) |
| Oct 30, 2018 | 167 | Notice (Other) (2) |
| Oct 30, 2018 | 167 | Exhibit 1 (15) |
| Oct 30, 2018 | 167 | Exhibit 2 (13) |
| Oct 30, 2018 | 167 | Main Document (2) Docket Text: NOTICE of Subpoenas to Hospira, Inc. by Apotex Corp., Apotex Inc. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Phillips, John) |
| Oct 29, 2018 | 166 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Rajesh Khanna on November 20, 2018 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Oct 26, 2018 | 165 | Notice (Other) (1) Docket Text: NOTICE of Intent to Redact Transcript of October 19, 2019 Telephone Conference by Slayback Pharma Limited Liability Company (Ormerod, Eve) |
| Oct 19, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held with Cephalon and Slayback on 10/19/2018. (Court Reporter V. Gunning.) (fms) |
| Oct 19, 2018 | N/A | SO ORDERED (0) |
| Oct 19, 2018 | 164 | Status Report (10) |
| Oct 19, 2018 | 164 | Exhibit A (21) |
| Oct 19, 2018 | 164 | Main Document (10) Docket Text: Joint STATUS REPORT by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A)(Hoeschen, Nathan) |
| Oct 18, 2018 | N/A | Set/Reset Hearings (0) |
| Oct 16, 2018 | 158 | Disclosure Statement (2) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fresenius Kabi Pharmaceuticals Holding, LLC, Other Affiliate Fresenius Kabi AG, Other Affiliate Fresenius SE & Co. KGaA for Fresenius Kabi USA, LLC filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Oct 16, 2018 | 159 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Log of Privileged Documents of Cephalon, Inc. (2) Eagle Pharmaceuticals, Inc.'s Privilege Log (3) Teva's Privilege Log (Witheld) (4) Teva's Privilege Log (Redacted) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Oct 16, 2018 | 160 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Fresenius Kabi USA, LLC's Privilege Logs filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Oct 16, 2018 | 161 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant Mylan's Privilege Log filed by Mylan Laboratories Limited.(Lennon, James) |
| Oct 16, 2018 | 162 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Log of Privileged Documents of Apotex Inc. and Apotex Corp.; and (2) Log of Redacted Privileged Documents of Apotex Inc. and Apotex Corp. filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
| Oct 16, 2018 | 163 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendant Slayback Pharma Limited Liability Company's Privilege Log filed by Slayback Pharma Limited Liability Company.(Ormerod, Eve) |
| Oct 12, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Oct 11, 2018 | 157 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of SAURABH BHASIN on October 23, 2018 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Oct 10, 2018 | 155 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of 1) Scidose LLC's Objections and Responses to Defendants' Subpoenas 2) Michael N. Mercanti's Objections and Responses to Defendants' Subpoena 3) Lucas & Mercanti, LLP's Objections and Responses to Defendants' Subpoena 4) Therdose Pharma Pvt. Ltd. and Therdose LLC's Objections and Responses to Defendants' Subpoenas filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Oct 10, 2018 | 156 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Response to Notice of Rule 30(b)(6) Deposition of Apotex Inc. and Apotex Corp. filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
| Oct 8, 2018 | 154 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of 1) Philip Christopher Buxton's Objections and Responses to Defendants' Subpoena 2) Nagesh R. Palepu's Objections and Responses to Defendants' Subpoena and 3) Srikanth Sundaram's Objections and Responses to Defendants' Subpoena filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Oct 5, 2018 | N/A | Oral Order (0) |
| Oct 5, 2018 | 153 | Stipulation to EXTEND Time (1) Docket Text: Joint STIPULATION TO EXTEND TIME Time to File Answering Brief in Opposition to Plaintiff's Motion to Dismiss and Reply Brief in Support of Plaintiff's Motion to Dismiss to December 21, 2018 and January 18, 2019 - filed by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Oct 2, 2018 | N/A | SO ORDERED (0) |
| Oct 1, 2018 | 152 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to file Motions to Amend Pleadings to 10/15/2018 - filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Sep 27, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 26, 2018 | N/A | SO ORDERED (0) |
| Sep 26, 2018 | 149 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Imron T. Aly - filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Sep 26, 2018 | 150 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendants' Notice of Rule 30(b)(6) Deposition filed by Eagle Pharmaceuticals, Inc..(Hoeschen, Nathan) |
| Sep 26, 2018 | 151 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses and Objections to Defendants' First Set of Joint Interrogatories (Nos. 1-7) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Sep 25, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:17-cv-01154-CFC, 1:17-cv-01164-CFC, 1:17-cv-01201-CFC, 1:17-cv-01790-CFC, 1:18-cv-00117-CFC (rjb) |
| Sep 24, 2018 | N/A | SO ORDERED (0) |
| Sep 24, 2018 | 148 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Responses and Objections to Defendants' Notice of Rule 30(b)(6) Deposition filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Sep 19, 2018 | 146 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Beth C. Finkelstein - filed by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Sep 19, 2018 | 147 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Defendant Mylan Laboratories Limiteds Notice of Subpoena of SciDose LLC 2.Defendant Mylan Laboratories Limiteds Notice of Subpoena of Lucas & Mercanti 3. Defendant Mylan Laboratories Limiteds Notice of Subpoena of TherDose Pharma Pvt. Ltd. 4. Defendant Mylan Laboratories Limiteds Notice of Subpoena of SciDose LLC 5. Defendant Mylan Laboratories Limiteds Notice of Subpoena of Michael N. Mercanti 6.Defendant Mylan Laboratories Limiteds Notice of Subpoena of TherDose Pharma filed by Mylan Laboratories Limited.(Lennon, James) |
| Sep 18, 2018 | N/A | SO ORDERED (0) |
| Sep 18, 2018 | 145 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of M.S. Vijaykanth (Amended) on October 11, 2018 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Sep 17, 2018 | 141 | Redacted Document (20) Docket Text: REDACTED VERSION of [133] Notice (Other) by Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Sep 17, 2018 | 142 | Redacted Document (20) Docket Text: REDACTED VERSION of [134] Notice (Other) by Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Sep 17, 2018 | 143 | Redacted Document (20) Docket Text: REDACTED VERSION of [132] Notice (Other) by Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Sep 17, 2018 | 144 | Stipulation (1) Docket Text: Joint STIPULATION to Extend Defendant's Answering Brief Deadline until October 10, 2018, and Plaintiff's Reply Brief Deadline until October 31, 2018 by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Sep 14, 2018 | 139 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Anil Sharma on October 9, 2018 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Sep 14, 2018 | 140 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Kurt Pearl on October 4, 2018 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Sep 13, 2018 | 137 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of MONIKA AGGARWAL on September 20, 2018 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Sep 13, 2018 | 138 | Amended Document (2) Docket Text: AMENDED DOCUMENT by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. Amendment to [137] Notice to Take Deposition [AMENDED NOTICE OF DEPOSITION OF MONIKA AGGARWAL]. (Hoeschen, Nathan) |
| Sep 12, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 11, 2018 | 135 | Stipulation (1) Docket Text: Joint STIPULATION to Extend Defendant's Answering Brief Deadline until September 19, 2018, and Plaintiff's Reply Brief Deadline until October 10, 2018 by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Sep 11, 2018 | 136 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Fresenius Kabi USA, LLC's Objections and Responses to Plaintiffs' Notice of Rule 30(b)(6) Deposition filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 10, 2018 | 128 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Philip Christopher Buxton on 11/8/2018 filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 10, 2018 | 129 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Nagesh R. Palepu on 11/13/2018 filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 10, 2018 | 130 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Srikanth Sundarum on 10/16/2018 filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 10, 2018 | 131 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Scott L. Tarriff on 10/22/2018 filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 7, 2018 | 127 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendant Fresenius Kabi USA, LLC's First Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (ii) Defendant Fresenius Kabi USA, LLC's First Amended Initial Disclosures Pursuant to Paragraph 3 of The Default Standard for Discovery filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 6, 2018 | 125 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of GEETANJALI BECTOR on September 20, 2018 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Sep 6, 2018 | 126 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of PRAVEEN KUMAR SUBBAPPA on September 21, 2018 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Aug 30, 2018 | N/A | SO ORDERED (0) |
| Aug 29, 2018 | 124 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bobby Delafield - filed by Mylan Laboratories Limited. (Lennon, James) |
| Aug 23, 2018 | 122 | Redacted Document (4) Docket Text: REDACTED VERSION of [115] Letter by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Aug 23, 2018 | 123 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Notice of Rule 30(b)(6) Deposition of Plaintiffs Cephalon, Inc. and Teva Pharmaceuticals International Gmbh and (2) Notice of Rule 30(b)(6) Deposition of Plaintiff Eagle Pharmaceuticals, Inc. filed by Mylan Laboratories Limited.(Lennon, James) |
| Aug 21, 2018 | 119 | Redacted Document (30) Docket Text: REDACTED VERSION of [108] Letter by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Aug 21, 2018 | 120 | Redacted Document (8) Docket Text: REDACTED VERSION of [110] MEMORANDUM in Support, by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Aug 21, 2018 | 121 | Redacted Document (22) Docket Text: REDACTED VERSION of [112] Opening Brief in Support, by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Aug 20, 2018 | N/A | SO ORDERED (0) |
| Aug 17, 2018 | 118 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to File Briefs Regarding Plaintiffs Motion to Dismiss for Lack of Jurisdiction Over the Subject Matter to September 12, 2018 and October 3, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Aug 16, 2018 | 114 | Response to Motion (3) |
| Aug 16, 2018 | 114 | Exhibit A (4) |
| Aug 16, 2018 | 116 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Notice of Rule 30(b)(6) Deposition of Defendant Mylan Laboratories Ltd. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Aug 16, 2018 | N/A | Order (0) |
| Aug 16, 2018 | 114 | Main Document (3) Docket Text: RESPONSE to Motion re [109] Emergency MOTION to Stay Claim Construction Proceedings filed by Fresenius Kabi USA, LLC. (Attachments: # (1) Exhibit A)(Farnan, Brian) |
| Aug 15, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 15, 2018 | N/A | Order (0) |
| Aug 14, 2018 | N/A | SO ORDERED (0) |
| Aug 14, 2018 | N/A | SO ORDERED (0) |
| Aug 14, 2018 | 109 | Text of Proposed Order (1) |
| Aug 14, 2018 | 109 | Rule 7.1.1 Statement (2) |
| Aug 14, 2018 | 111 | Text of Proposed Order (1) |
| Aug 14, 2018 | 109 | Main Document (2) Docket Text: Emergency MOTION to Stay Claim Construction Proceedings - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Text of Proposed Order, # (2) Rule 7.1.1 Statement)(Keller, Karen) |
| Aug 14, 2018 | 111 | Main Document (2) Docket Text: MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Text of Proposed Order)(Keller, Karen) |
| Aug 13, 2018 | 106 | Redacted Document (30) Docket Text: REDACTED VERSION of [101] Reply to Response to Motion, by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Shaw, John) |
| Aug 13, 2018 | 107 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Constance S. Huttner - filed by Slayback Pharma Limited Liability Company. (Belgam, Neal) |
| Aug 10, 2018 | 105 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit Opening and Answering Claim Construction Briefs to August 21, 2018 and August 28, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Aug 9, 2018 | 104 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Apotex' response re: separate claim construction hearing and expedited briefing on indefiniteness issues - re [102] Letter, [98] Letter. (Phillips, John) |
| Aug 8, 2018 | N/A | SO ORDERED (0) |
| Aug 7, 2018 | 103 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to file Opening Claim Construction Briefs to August 14, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Aug 6, 2018 | 99 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Kiran Krishnan filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Aug 6, 2018 | 100 | Redacted Document (7) |
| Aug 6, 2018 | 100 | Exhibit A (22) |
| Aug 6, 2018 | 102 | Letter (3) |
| Aug 6, 2018 | 102 | Exhibit A (4) |
| Aug 6, 2018 | 100 | Main Document (7) Docket Text: REDACTED VERSION of [95] Response to Motion, by Apotex Corp., Apotex Inc.. (Attachments: # (1) Exhibit A)(Haney, Megan) |
| Aug 6, 2018 | 102 | Main Document (3) Docket Text: Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding Response to Defendants Fresenius Kabi and Mylan's August 4, 2018 - re [98] Letter. (Attachments: # (1) Exhibit A)(Keller, Karen) |
| Aug 4, 2018 | 98 | Letter (2) Docket Text: Letter to The Honorable Leonard P. Stark from Brian E. Farnan regarding Rescheduling Markman Hearing. (Farnan, Brian) |
| Aug 3, 2018 | 97 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding Sealed Consent Judgment and Stipulation of Dismissal - re (18 in 1:17-cv-01790-LPS) Proposed Consent Judgment. (Keller, Karen) |
| Aug 2, 2018 | 96 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding Proposed Consent Judgment and Stipulation of Dismissal - re (24 in 1:17-cv-01201-LPS) Proposed Consent Judgment. (Keller, Karen) |
| Jul 25, 2018 | N/A | Case Assigned/Reassigned (0) |
| Jul 24, 2018 | N/A | SO ORDERED (0) |
| Jul 24, 2018 | 93 | Stipulation (2) Docket Text: STIPULATION (and Proposed Order) of Partial Dismissal by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jul 24, 2018 | 94 | Claim Construction Chart (22) Docket Text: CLAIM Construction Chart by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jul 23, 2018 | N/A | Oral Order (0) |
| Jul 23, 2018 | 92 | Redacted Document (30) Docket Text: REDACTED VERSION of [90] MOTION for Issuance of Letter of Request for International Judicial Assistance Pursuant to The Hague Convention of March 18, 1970 by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Jul 20, 2018 | N/A | Oral Order (0) |
| Jul 17, 2018 | 91 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to extend the deadline to submit Joint Claim Chart to July 24, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jul 13, 2018 | 87 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendants' Second Set of Requests for Production of Documents and Things (Nos. 28-37) filed by Eagle Pharmaceuticals, Inc..(Keller, Karen) |
| Jul 13, 2018 | 88 | SO ORDERED (2) Docket Text: SO ORDERED - re [86] STIPULATION TO EXTEND TIME to submit a Joint Claim Chart to July 17, 2018 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc.. Signed by Judge Gregory M. Sleet on 7/13/2018. (mdb) |
| Jul 13, 2018 | 89 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Responses and Objections to Defendants' Second Requests for Production of Documents and Things filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Jul 10, 2018 | 86 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a Joint Claim Chart to July 17, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jun 29, 2018 | 84 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Responses and Objections to Defendants' First Requests for Production of Documents and Things filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Jun 29, 2018 | 85 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Requests for Production of Documents and Things (Nos. 1-26) filed by Eagle Pharmaceuticals, Inc..(Hoeschen, Nathan) |
| Jun 20, 2018 | N/A | SO ORDERED (0) |
| Jun 18, 2018 | 83 | Stipulation (2) Docket Text: STIPULATION (and proposed Order) to Extend time to submit Joint Claim Chart to July 20, 2018 by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jun 14, 2018 | 79 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendant Slayback Pharma Limited Liability Company's Responses and Objections to Plaintiffs' Second Set of Requests for Production filed by Slayback Pharma Limited Liability Company.(Ormerod, Eve) |
| Jun 14, 2018 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Responses to Plaintiffs' Second Set of Requests for Production filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
| Jun 14, 2018 | 81 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Mylan Laboratories Ltd.S Responses and Objections to Plaintiffs Second Set of Requests For Production [Nos. 96-102] filed by Mylan Laboratories Limited.(Lennon, James) |
| Jun 14, 2018 | 82 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Fresenius Kabi USA, LLC's Objections and Responses to Plaintiffs' Second Set of Requests for Production filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Jun 13, 2018 | N/A | SO ORDERED (0) |
| Jun 13, 2018 | 78 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Apotex Inc. and Apotex Corp., Slayback Pharma Limited Liability Company, Fresenius Kabi USA, LLC and Mylan Laboratories Limited's Second Requests for Production of Documents and Things to Plaintiff Eagle Pharmaceuticals, Inc.; and (2) Defendants Slayback Pharma Limited Liability Company, Apotex Inc and Apotex Corp., Fresenius Kabi USA, LLC, and Mylan Laboratories Limited's Second Requests for Production of Documents and Things to Plaintiffs Teva Pharmaceuticals International GMBH and Cephalon, Inc. filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
| Jun 12, 2018 | 77 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file Joint Claim Chart to 6/19/2018 - filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Jun 6, 2018 | N/A | SO ORDERED (0) |
| Jun 5, 2018 | 76 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file Joint Claim Chart to 6/12/2018 - filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| May 31, 2018 | N/A | SO ORDERED (0) |
| May 31, 2018 | 75 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendants Slayback Pharma Limited Liability Company, Apotex Inc., Apotex Corp., Fresenius Kabi USA, LLC, and Mylan Laboratories Limited's First Requests for Production of Documents and Things to Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc. and (ii) 2.Defendants Slayback Pharma Limited Liability Company, Apotex Inc., Apotex Corp., Fresenius Kabi USA, LLC, and Mylan Laboratories Limited's First Requests for Production of Documents and Things to Plaintiff Eagle Pharmaceuticals, Inc. filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| May 29, 2018 | 74 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a Joint Claim Chart to June 5, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| May 22, 2018 | N/A | SO ORDERED (0) |
| May 21, 2018 | 73 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Production to Defendants Apotex Inc. and Apotex Corp.; Plaintiffs' Second Set of Requests for Production to Defendant Fresenius Kabi USA, LLC; Plaintiffs' Second Set of Requests for Production to Defendant Slayback Pharma Limited Liability Co.; and Plaintiffs' Second Set of Requests for Production to Defendant Mylan Laboratories Ltd. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| May 18, 2018 | 72 | Stipulation (2) Docket Text: STIPULATION (and proposed order) to Extend Time to submit a joint claim chart on May 29, 2018 by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| May 9, 2018 | 71 | SO ORDERED (2) Docket Text: SO ORDERED - re [70] Stipulation (and proposed order) to abide by protective order filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc.. Signed by Judge Gregory M. Sleet on 5/9/2018. (mdb) |
| May 1, 2018 | 68 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Mylan Laboratories Ltd.'s Objections and Responses to Plaintiffs' First Set of Interrogatories filed by Mylan Laboratories Limited.(Lennon, James) |
| May 1, 2018 | 69 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Pro Hac Vice Counsel Anna Phillips by Mylan Laboratories Limited (Lennon, James) |
| May 1, 2018 | 70 | Stipulation (2) Docket Text: STIPULATION (and proposed order) to abide by protective order by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) Modified on 5/2/2018 (mdb). |
| Apr 30, 2018 | 65 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Objections and Answers to Plaintiffs' First Set of Interrogatories filed by Apotex Corp., Apotex Inc..(Bilson, David) |
| Apr 30, 2018 | 66 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendant Slayback Pharma Limited Liability Company's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-12) filed by Slayback Pharma Limited Liability Company.(Ormerod, Eve) |
| Apr 30, 2018 | 67 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Fresenius Kabi USA, LLC's Objections and Responses to Plaintiffs' First Set of Interrogatories filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Apr 24, 2018 | 64 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Mylan's Responses and Objections to Plaintiffs First Set of Requests for Production filed by Mylan Laboratories Limited.(Lennon, James) |
| Apr 16, 2018 | 63 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Responses and Objections to Defendants First of Joint Interrogatories (Nos. 1-7) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Apr 2, 2018 | 62 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants Apotex Inc. and Apotex Corp.; Plaintiffs' First Set of Interrogatories to Defendant Fresenius Kabi USA, LLC; Plaintiffs' Initial Infringement Contentions for Slayback Pharma Limited Liability Co.; and Plaintiffs' First Set of Interrogatories to Defendant Mylan Laboratories Ltd. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Mar 23, 2018 | 61 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Invalidity Contentions filed by Mylan Laboratories Limited.(Lennon, James) |
| Mar 15, 2018 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories (Nos. 1-7) filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Mar 12, 2018 | N/A | SO ORDERED (0) |
| Mar 12, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Mar 9, 2018 | 57 | Transcript (20) Docket Text: Official Transcript of Telephone Conference held on 02 27 18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 4/2/2018. Redacted Transcript Deadline set for 4/9/2018. Release of Transcript Restriction set for 6/7/2018. (kjm) |
| Mar 9, 2018 | 58 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Elise M. Baumgarten - filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Mar 9, 2018 | 59 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production to Defendant Mylan Laboratories Ltd. (2) Plaintiffs' Initial Infringement Contentions for Mylan Laboratories Ltd. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Mar 5, 2018 | 55 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Mylan Laboratories Limiteds Disclosures Pursuant to Paragrah 3 of D. Dels Default Standard for Discovery, and Mylan Laboratories Limiteds Rule 26(a)(1) Initial Disclosures filed by Mylan Laboratories Limited.(Lennon, James) |
| Mar 5, 2018 | 56 | Answer to Counterclaim (6) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaims by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Shaw, John) Modified on 3/5/2018 (mdb). |
| Mar 2, 2018 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Identification of Asserted Patents and Accused Products filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Mar 2, 2018 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Plaintiff Eagle Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Delaware Default Standard for Discovery and 2) Plaintiff Eagle Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) filed by Eagle Pharmaceuticals, Inc..(Hoeschen, Nathan) |
| Mar 2, 2018 | 54 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Mar 1, 2018 | N/A | SO ORDERED (0) |
| Mar 1, 2018 | N/A | SO ORDERED (0) |
| Feb 27, 2018 | N/A | Telephone Conference (0) |
| Feb 27, 2018 | N/A | SO ORDERED (0) |
| Feb 27, 2018 | 49 | Stipulation (2) Docket Text: STIPULATION And [Proposed Order] Relating To Discovery, Including Discovery Of Electronically Stored Information by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) Modified on 2/27/2018 (mdb). |
| Feb 27, 2018 | 50 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME [Between Plaintiffs and Mylan Laboratories Ltd.] to March 2, 2018, March 9, 2018 and March 23, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Feb 23, 2018 | 48 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Feb 22, 2018 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex's Response to Plaintiffs' First Set of Requests for Production filed by Apotex Corp., Apotex Inc..(Bilson, David) |
| Feb 21, 2018 | N/A | SO ORDERED (0) |
| Feb 21, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Feb 21, 2018 | 45 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendant Slayback Pharma Limited Liability Companys Responses and Objections to Plaintiffs' First Set of Requests for Production filed by Slayback Pharma Limited Liability Company.(Ormerod, Eve) |
| Feb 21, 2018 | 46 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Fresenius Kabi USA, LLC's Objections and Responses to Plaintiffs' First Set of Requests for Production filed by Fresenius Kabi USA, LLC.(Farnan, Michael) |
| Feb 20, 2018 | N/A | SO ORDERED (0) |
| Feb 20, 2018 | 44 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to file an order regarding the Production of Electronically Stored Information to 2/27/2018 - filed by Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Feb 16, 2018 | 43 | Proposed Order (24) Docket Text: PROPOSED ORDER [Protective Order] by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 14, 2018 | N/A | SO ORDERED (0) |
| Feb 13, 2018 | 42 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to File ESI Order to February 20, 2018 - filed by Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Feb 12, 2018 | N/A | SO ORDERED (0) |
| Feb 9, 2018 | 40 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to the First Requests for Production of Documents and Things to Plaintiffs from Defendants Apotex Inc. and Slayback Pharma Limited Liability Co. (Nos. 1-55) (2) Plaintiffs Teva Pharmaceuticals International Gmbh, and Cephalon, Inc.'s Responses and Objections to Defendants Apotex Inc.'s and Slayback Pharma Limited Liability Co.'s First Requests for Production of Documents and Things to Plaintiffs (Nos. 1-55) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Feb 9, 2018 | 41 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to extend the deadline to submit a Proposed Protective Order to February 16, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Feb 8, 2018 | N/A | Oral Order (0) |
| Feb 5, 2018 | N/A | SO ORDERED (0) |
| Feb 2, 2018 | 39 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Protective Order to February 9, 2018 - filed by Fresenius Kabi USA, LLC. (Farnan, Michael) |
| Jan 30, 2018 | 38 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by David A. Bilson on behalf of Apotex Corp., Apotex Inc. (Bilson, David) |
| Jan 29, 2018 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendant Fresenius Kabi USA, LLC's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and (ii) Defendant Fresenius Kabi USA, LLC's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Jan 26, 2018 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Eagle Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) (2) Plaintiff Eagle Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Delaware Default Standard for Discovery (3) Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Jan 26, 2018 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Slayback Pharma Limited Liability Company's Initial Disclosures Pursuant to Rule 26(a)(1) and Initial Disclosures Pursuant to Paragraph 3 of the Default Standard of Discovery, Including Discovery of Electronically Stored Information filed by Slayback Pharma Limited Liability Company.(Ormerod, Eve) |
| Jan 26, 2018 | 35 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Infringement Contentions For Apotex Inc. and Apotex Corp. (2) Plaintiffs' Initial Infringement Contentions for Slayback (3) Plaintiffs' Initial Infringement Contentions for Fresenius Kabi filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| Jan 26, 2018 | 36 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Apotex Inc.'s and Apotex Corp.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery; and (2) Defendants Apotex Inc.'s and Apotex Corp.'s Rule 26(a)(1) Initial Disclosures filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
| Jan 24, 2018 | N/A | SO ORDERED (0) |
| Jan 19, 2018 | 32 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to file a Proposed Protective Order to February 2, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Jan 17, 2018 | N/A | SO ORDERED (0) |
| Jan 15, 2018 | 31 | Certification of Daniel R. Cherry (1) |
| Jan 15, 2018 | 31 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daniel R. Cherry - filed by Apotex Corp., Apotex Inc.. (Attachments: # (1) Certification of Daniel R. Cherry)(Haney, Megan) |
| Jan 12, 2018 | 30 | Proposed Order (12) |
| Jan 12, 2018 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendant Fresenius Kabi USA, LLC's First Set of Requests for the Production of Documents and Things (Nos. 1-42) (2) Plaintiffs Teva Pharmaceuticals International, GMBH, and Cephalon, Inc.'s Responses and Objections to Defendant Fresenius Kabi USA, LLC's First Set of Requests for the Production of Documents and Things (Nos. 1-42) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc..(Hoeschen, Nathan) |
| Jan 12, 2018 | 30 | Letter to the Honorable Gregory M. Sleet (1) |
| Jan 12, 2018 | 30 | Main Document (12) Docket Text: PROPOSED ORDER [Scheduling Order] re SO ORDERED by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Letter to the Honorable Gregory M. Sleet)(Hoeschen, Nathan) |
| Jan 10, 2018 | N/A | SO ORDERED (0) |
| Jan 10, 2018 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Apotex Inc.'s and Slayback Pharma Limited Liability Co.'s First Requests for Production of Documents and Things to Plaintiffs (Nos. 1-55) filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
| Jan 5, 2018 | 27 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to January 12, 2018 - filed by Apotex Corp., Apotex Inc.. (Phillips, John) |
| Dec 22, 2017 | N/A | SO ORDERED (0) |
| Dec 22, 2017 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Slayback Pharma Limited Liability Company's Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard of Discovery, Including Discovery of Electronically Stored Information filed by Slayback Pharma Limited Liability Company.(Ormerod, Eve) |
| Dec 22, 2017 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Fresenius Kabi USA, LLC's Production of Core Technical Documents, bearing Bates numbers FK_BENDA_00000001 - FK_BENDA_00003153 filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Dec 22, 2017 | 26 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs' First Set of Requests for Production to Defendants Apotex Inc. and Apotex Corp.; 2) Plaintiffs' First Set of Requests for Production to Defendant Fresenius Kabi USA, LLC; and 3) Plaintiffs' First Set of Requests for Production to Defendant Slayback Pharma Limited Liability Co. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Dec 20, 2017 | N/A | SO ORDERED (0) |
| Dec 20, 2017 | 23 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to January 5, 2018 - filed by Apotex Corp., Apotex Inc.. (Phillips, John) |
| Dec 18, 2017 | 22 | Answer to Counterclaim (14) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim (Apotex Inc. And Apotex Corp.'s Counterclaims) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) Modified on 12/22/2017 (mdb). |
| Dec 14, 2017 | 21 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ben V. Picozzi - filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 13, 2017 | N/A | Remark (0) |
| Dec 13, 2017 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 12/13/2017. Discussion about the competing schedule proposals between the parties. After counsel conferred outside of court's presence, the court assigns the following dates: A Markman Hearing (full day) is set for 9/4/2018 at 9:30 AM in Courtroom 4A, the Final Proposed Pretrial Order is due by the close of business on 7/29/2019, the Final Pretrial Conference is set for 8/19/2019 at 10:00 AM in Courtroom 4A, and a 10-day Bench Trial is set for 9/3/2019 at 9:00 AM in Courtroom 4A. These cases are consolidated for all purposes; all future filings are to be made ONLY in Lead C.A. No. 17-1154-GMS. These cases will not be referred to the Magistrate Judge for exploring ADR. The plaintiffs shall file an amended scheduling order within seven (7) days of today. (Court Reporter Kevin Maurer.) Associated Cases: 1:17-cv-01154-GMS, 1:17-cv-01164-GMS, 1:17-cv-01201-GMS(mdb) |
| Dec 7, 2017 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Identification of Asserted Patents and Accused Products filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc..(Keller, Karen) |
| Dec 1, 2017 | N/A | Oral Order (0) |
| Nov 7, 2017 | 18 | Status Report (13) Docket Text: Joint STATUS REPORT by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Nov 7, 2017 | 19 | Proposed Order (13) Docket Text: PROPOSED ORDER [Scheduling Order] by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Nov 2, 2017 | N/A | SO ORDERED (0) |
| Oct 30, 2017 | 17 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Schedule and Joint Status Report to November 7, 2017 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Oct 20, 2017 | 16 | Answer to Counterclaim (6) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaims by Cephalon, Inc., Eagle Pharmaceuticals, Inc..(Hoeschen, Nathan) Modified on 10/23/2017 (mdb). |
| Oct 18, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Oct 13, 2017 | N/A | SO ORDERED (0) |
| Oct 12, 2017 | N/A | SO ORDERED (0) |
| Oct 12, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Oct 12, 2017 | 15 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Oct 11, 2017 | 14 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Marc N. Zubick, Daniel G. Brown, and Michelle L. Ernst - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Oct 5, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Oct 5, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Oct 2, 2017 | N/A | SO ORDERED (0) |
| Sep 29, 2017 | 10 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez and James P. Barabas - filed by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Sep 29, 2017 | 11 | Answer to Complaint (24) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Cephalon, Inc., Eagle Pharmaceuticals, Inc. by Slayback Pharma Limited Liability Company.(Ormerod, Eve) |
| Sep 29, 2017 | 12 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate KKR & Co. for Slayback Pharma Limited Liability Company filed by Slayback Pharma Limited Liability Company. (Ormerod, Eve) |
| Sep 29, 2017 | 13 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 9/29/2017. (asw) |
| Sep 6, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 6, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 6, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 6, 2017 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 1, 2017 | N/A | SO ORDERED (0) |
| Sep 1, 2017 | N/A | SO ORDERED (0) |
| Aug 31, 2017 | 9 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to Move, Answer or otherwise Respond to the Complaint to October 23, 2017 - filed by Slayback Pharma Limited Liability Company. (Belgam, Neal) |
| Aug 30, 2017 | 8 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber, Martha C. Kidd and Shaun P. Mahaffy - filed by Cephalon, Inc.. (Hoeschen, Nathan) |
| Aug 23, 2017 | N/A | Case Assigned/Reassigned (0) |
| Aug 17, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Slayback Pharma Limited Liability Company on 8/17/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Aug 17, 2017 | 7 | Summons Returned Executed (1) Docket Text: SUMMONS Returned Executed by Eagle Pharmaceuticals, Inc., Cephalon, Inc.. Slayback Pharma Limited Liability Company served on 8/17/2017, answer due 9/7/2017. (Shaw, John) |
| Aug 16, 2017 | 1 | Exhibit A (29) |
| Aug 16, 2017 | 1 | Civil Cover Sheet (1) |
| Aug 16, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Aug 16, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/6/2017. Date of Expiration of Patent: 1/12/2026.Thirty Month Stay Deadline: 1/6/2020. (ceg) |
| Aug 16, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,791,270 B2. (ceg) |
| Aug 16, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd for Cephalon, Inc. filed by Cephalon, Inc. (ceg) |
| Aug 16, 2017 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc. (ceg) |
| Aug 16, 2017 | 1 | Main Document (11) Docket Text: COMPLAINT for Patent Infringement filed against Slayback Pharma Limited Liability Company - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2205093.) - filed by Eagle Pharmaceuticals, Inc., Cephalon, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(ceg) |
